These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
353 related articles for article (PubMed ID: 15292260)
1. Histone deacetylase 3 interacts with runx2 to repress the osteocalcin promoter and regulate osteoblast differentiation. Schroeder TM; Kahler RA; Li X; Westendorf JJ J Biol Chem; 2004 Oct; 279(40):41998-2007. PubMed ID: 15292260 [TBL] [Abstract][Full Text] [Related]
2. Runx2- and histone deacetylase 3-mediated repression is relieved in differentiating human osteoblast cells to allow high bone sialoprotein expression. Lamour V; Detry C; Sanchez C; Henrotin Y; Castronovo V; Bellahcène A J Biol Chem; 2007 Dec; 282(50):36240-9. PubMed ID: 17956871 [TBL] [Abstract][Full Text] [Related]
3. Runx2 (Cbfa1, AML-3) interacts with histone deacetylase 6 and represses the p21(CIP1/WAF1) promoter. Westendorf JJ; Zaidi SK; Cascino JE; Kahler R; van Wijnen AJ; Lian JB; Yoshida M; Stein GS; Li X Mol Cell Biol; 2002 Nov; 22(22):7982-92. PubMed ID: 12391164 [TBL] [Abstract][Full Text] [Related]
5. Zfp521 controls bone mass by HDAC3-dependent attenuation of Runx2 activity. Hesse E; Saito H; Kiviranta R; Correa D; Yamana K; Neff L; Toben D; Duda G; Atfi A; Geoffroy V; Horne WC; Baron R J Cell Biol; 2010 Dec; 191(7):1271-83. PubMed ID: 21173110 [TBL] [Abstract][Full Text] [Related]
6. Activation of peroxisome proliferator-activated receptor-gamma inhibits the Runx2-mediated transcription of osteocalcin in osteoblasts. Jeon MJ; Kim JA; Kwon SH; Kim SW; Park KS; Park SW; Kim SY; Shin CS J Biol Chem; 2003 Jun; 278(26):23270-7. PubMed ID: 12704187 [TBL] [Abstract][Full Text] [Related]
7. NFATc1 mediates HDAC-dependent transcriptional repression of osteocalcin expression during osteoblast differentiation. Choo MK; Yeo H; Zayzafoon M Bone; 2009 Sep; 45(3):579-89. PubMed ID: 19463978 [TBL] [Abstract][Full Text] [Related]
8. Histone deacetylase 7 associates with Runx2 and represses its activity during osteoblast maturation in a deacetylation-independent manner. Jensen ED; Schroeder TM; Bailey J; Gopalakrishnan R; Westendorf JJ J Bone Miner Res; 2008 Mar; 23(3):361-72. PubMed ID: 17997710 [TBL] [Abstract][Full Text] [Related]
9. Cooperative interactions between activating transcription factor 4 and Runx2/Cbfa1 stimulate osteoblast-specific osteocalcin gene expression. Xiao G; Jiang D; Ge C; Zhao Z; Lai Y; Boules H; Phimphilai M; Yang X; Karsenty G; Franceschi RT J Biol Chem; 2005 Sep; 280(35):30689-96. PubMed ID: 16000305 [TBL] [Abstract][Full Text] [Related]
11. EGFR signaling suppresses osteoblast differentiation and inhibits expression of master osteoblastic transcription factors Runx2 and Osterix. Zhu J; Shimizu E; Zhang X; Partridge NC; Qin L J Cell Biochem; 2011 Jul; 112(7):1749-60. PubMed ID: 21381079 [TBL] [Abstract][Full Text] [Related]
12. Nrf2 negatively regulates osteoblast differentiation via interfering with Runx2-dependent transcriptional activation. Hinoi E; Fujimori S; Wang L; Hojo H; Uno K; Yoneda Y J Biol Chem; 2006 Jun; 281(26):18015-24. PubMed ID: 16613847 [TBL] [Abstract][Full Text] [Related]
13. Transcriptional induction of the osteocalcin gene during osteoblast differentiation involves acetylation of histones h3 and h4. Shen J; Hovhannisyan H; Lian JB; Montecino MA; Stein GS; Stein JL; Van Wijnen AJ Mol Endocrinol; 2003 Apr; 17(4):743-56. PubMed ID: 12554783 [TBL] [Abstract][Full Text] [Related]
14. General transcription factor IIA-gamma increases osteoblast-specific osteocalcin gene expression via activating transcription factor 4 and runt-related transcription factor 2. Yu S; Jiang Y; Galson DL; Luo M; Lai Y; Lu Y; Ouyang HJ; Zhang J; Xiao G J Biol Chem; 2008 Feb; 283(9):5542-53. PubMed ID: 18171674 [TBL] [Abstract][Full Text] [Related]
15. Two of four alternatively spliced isoforms of RUNX2 control osteocalcin gene expression in human osteoblast cells. Makita N; Suzuki M; Asami S; Takahata R; Kohzaki D; Kobayashi S; Hakamazuka T; Hozumi N Gene; 2008 Apr; 413(1-2):8-17. PubMed ID: 18321663 [TBL] [Abstract][Full Text] [Related]
16. Identification of potential modifiers of Runx2/Cbfa1 activity in C2C12 cells in response to bone morphogenetic protein-7. Gu K; Zhang L; Jin T; Rutherford RB Cells Tissues Organs; 2004; 176(1-3):28-40. PubMed ID: 14745233 [TBL] [Abstract][Full Text] [Related]
17. Expression of the osteoblast differentiation factor RUNX2 (Cbfa1/AML3/Pebp2alpha A) is inhibited by tumor necrosis factor-alpha. Gilbert L; He X; Farmer P; Rubin J; Drissi H; van Wijnen AJ; Lian JB; Stein GS; Nanes MS J Biol Chem; 2002 Jan; 277(4):2695-701. PubMed ID: 11723115 [TBL] [Abstract][Full Text] [Related]
18. Repression of Runx2 function by TGF-beta through recruitment of class II histone deacetylases by Smad3. Kang JS; Alliston T; Delston R; Derynck R EMBO J; 2005 Jul; 24(14):2543-55. PubMed ID: 15990875 [TBL] [Abstract][Full Text] [Related]
19. Transient upregulation of CBFA1 in response to bone morphogenetic protein-2 and transforming growth factor beta1 in C2C12 myogenic cells coincides with suppression of the myogenic phenotype but is not sufficient for osteoblast differentiation. Lee MH; Javed A; Kim HJ; Shin HI; Gutierrez S; Choi JY; Rosen V; Stein JL; van Wijnen AJ; Stein GS; Lian JB; Ryoo HM J Cell Biochem; 1999 Apr; 73(1):114-25. PubMed ID: 10088730 [TBL] [Abstract][Full Text] [Related]
20. Histone demethylase Jmjd3 regulates osteoblast differentiation via transcription factors Runx2 and osterix. Yang D; Okamura H; Nakashima Y; Haneji T J Biol Chem; 2013 Nov; 288(47):33530-33541. PubMed ID: 24106268 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]